Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yayoi Kawata

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Therapeutic Innovation & Regulatory Science|October 28, 2024
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody DrugsHiromu Yoshiura, Yayoi Kawata, Shintaro Sengoku
Heliyon|February 16, 2022
Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesisYuko Katayama, Yayoi Kawata, Yusuke Moritoh, et al.
Frontiers in Neurology|July 21, 2025
Gender differences in prescribing patterns for patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databasesMorinobu Seki, Yayoi Kawata, Ayako Hayashi, et al.
Neuropsychopharmacology Reports|June 3, 2026
Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims DatabaseMasaki Kato, Tatsuya Hoshino, Yayoi Kawata, et al.
Lipids|November 16, 2007
LXR agonist increases the lymph HDL transport in rats by promoting reciprocally intestinal ABCA1 and apo A-I mRNA levelsMasao Sato, Yayoi Kawata, Kazuo Erami, et al.
Frontiers in Neurology|July 10, 2023
Prescribing patterns and determinants for elderly patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databasesMorinobu Seki, Yayoi Kawata, Ayako Hayashi, et al.
Drug Discovery Today|January 10, 2025
Multi-layer platform coordination for open innovation in oligonucleotide therapeuticsYayoi Kawata, Taisuke Ichimaru, Masakazu Kogami, et al.
The Journal of Nutrition|July 1, 2004
Phytosterol oxidation products are absorbed in the intestinal lymphatics in rats but do not accelerate atherosclerosis in apolipoprotein E-deficient miceHiroko Tomoyori, Yayoi Kawata, Tomoko Higuchi, et al.
Biochemical and Biophysical Research Communications|October 9, 2016
Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage displayKotaro Sakamoto, Yayoi Kawata, Yasushi Masuda, et al.
Patient Preference and Adherence|May 15, 2023
Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in JapanNobutaka Hattori, Yoshiko Okada, Yayoi Kawata, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Therapeutic Innovation & Regulatory Science|October 28, 2024
Open Innovation and Regulatory Challenges in New Modality Development: The Pivotal Role of Contract Development and Manufacturing Organisations in Advancing Antibody DrugsHiromu Yoshiura, Yayoi Kawata, Shintaro Sengoku
Heliyon|February 16, 2022
Dichloroacetate, a pyruvate dehydrogenase kinase inhibitor, ameliorates type 2 diabetes via reduced gluconeogenesisYuko Katayama, Yayoi Kawata, Yusuke Moritoh, et al.
Frontiers in Neurology|July 21, 2025
Gender differences in prescribing patterns for patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databasesMorinobu Seki, Yayoi Kawata, Ayako Hayashi, et al.
Neuropsychopharmacology Reports|June 3, 2026
Real-World Vortioxetine Prescription for Patients With Major Depressive Disorder in Japan: A Retrospective Cohort Study Using a Japanese Health Insurance Claims DatabaseMasaki Kato, Tatsuya Hoshino, Yayoi Kawata, et al.
Lipids|November 16, 2007
LXR agonist increases the lymph HDL transport in rats by promoting reciprocally intestinal ABCA1 and apo A-I mRNA levelsMasao Sato, Yayoi Kawata, Kazuo Erami, et al.
Frontiers in Neurology|July 10, 2023
Prescribing patterns and determinants for elderly patients with Parkinson's disease in Japan: a retrospective observational study using insurance claims databasesMorinobu Seki, Yayoi Kawata, Ayako Hayashi, et al.
Drug Discovery Today|January 10, 2025
Multi-layer platform coordination for open innovation in oligonucleotide therapeuticsYayoi Kawata, Taisuke Ichimaru, Masakazu Kogami, et al.
The Journal of Nutrition|July 1, 2004
Phytosterol oxidation products are absorbed in the intestinal lymphatics in rats but do not accelerate atherosclerosis in apolipoprotein E-deficient miceHiroko Tomoyori, Yayoi Kawata, Tomoko Higuchi, et al.
Biochemical and Biophysical Research Communications|October 9, 2016
Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage displayKotaro Sakamoto, Yayoi Kawata, Yasushi Masuda, et al.
Patient Preference and Adherence|May 15, 2023
Survey on the Impact of the COVID-19 Pandemic on Patients with Parkinson's Disease and Their Caregivers in JapanNobutaka Hattori, Yoshiko Okada, Yayoi Kawata, et al.
Pageof 2